<div id="readability-page-1">We came across a bullish thesis on Merck &amp; Co., Inc. on R. Dennis’s Substack’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on MRK. Merck &amp; Co., Inc.’s share was trading at $106.90 as of January 28th. MRK’s trailing and forward P/E were 14.28 and 17.27 respectively according to Yahoo Finance. Merck &amp; […]</div>

<p>A bullish thesis on Merck & Co., Inc. (MRK) was discussed on R. Dennis’s Substack by OppCost. As of January 28th, MRK shares were trading at $106.90, with trailing and forward P/E ratios of 14.28 and 17.27, respectively, according to Yahoo Finance.</p>

VG Health

SPDR S&P Biotech

Health Care Select Sector SPDR

Ark Genomic Revolution ETF

Direxion S&P Biotech Bear 3X

Proshares Ultra Nasdaq Biotech

iShares Global Healthcare

Merck

Invesco Nasdaq Biotechnology ETF

Invesco Biotechnology & Genome ETF

ALPS Medical Breakthrough

VanEck Biotech ETF

First Trust NYSE Arca Biotech Index Fd

iShares US Pharma

iShares Biotechnology ETF

Merck & Co., Inc. (MRK): A bull case theory